Viatris Inc. logo


Viatris Inc.


Earnings Summary

Net Profits
Net Profit Margins



Viatris Inc.’s revenue jumped 27.9% since last year same period to $3191.8Mn in the Q1 2020. On a quarterly growth basis, Viatris Inc. has generated 0% jump in its revenue since last 3-months.

Net Profits:

Viatris Inc.’s net profit jumped 182% since last year same period to $20.5Mn in the Q1 2020. On a quarterly growth basis, Viatris Inc. has generated 0% jump in its net profits since last 3-months.

Net Profit Margins:

Viatris Inc.’s net profit margin jumped 164.11% since last year same period to 0.64% in the Q1 2020. On a quarterly growth basis, Viatris Inc. has generated 0% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Viatris Inc. post its latest quarter earnings

EPS Estimate Current Quarter
EPS Estimate Current Year


EPS Estimate Current Quarter:

Viatris Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.72 - a -14.29% fall from last quarter’s estimates.

EPS Estimate Current Year:

Viatris Inc.’s earning per share (EPS) estimates for the current year stand at 0.72.

Key Ratios

Key ratios of the Viatris Inc. post its Q3 2022 earnings

Earning Per Share (EPS)
Return on Assets (ROA)
Return on Equity (ROE)
Dividend Per Share (DPS)


Earning Per Share (EPS):

Viatris Inc.’s earning per share (EPS) fell -12.12% since last year same period to 0.87 in the Q3 2022. This indicates that the Viatris Inc. has generated -12.12% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Viatris Inc.’s return on assets (ROA) stands at 0.04.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Viatris Inc.’s return on equity (ROE) stands at 0.04.

Dividend Per Share (DPS):

Viatris Inc. declared 0.12 dividend per share during the earnings announcement for Q3 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %

Company Information

Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. It provides access to medicines, advance sustainable operations, develop innovative solutions and leverage its collective expertise to connect more people to more products and services through its one-of-a-kind Global Healthcare GatewayTM. Formed in November 2020through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghaiand Hyderabad, India.

Viatris Inc.
1000 Mylan Boulevard, Canonsburg, PA, United States, 15317
Health Technology
Michael Goettler

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*